» Articles » PMID: 30819724

Atherogenic LOX-1 Signaling is Controlled by SPPL2-mediated Intramembrane Proteolysis

Abstract

The lectin-like oxidized LDL receptor 1 (LOX-1) is a key player in the development of atherosclerosis. LOX-1 promotes endothelial activation and dysfunction by mediating uptake of oxidized LDL and inducing pro-atherogenic signaling. However, little is known about modulators of LOX-1-mediated responses. Here, we show that the function of LOX-1 is controlled proteolytically. Ectodomain shedding by the metalloprotease ADAM10 and lysosomal degradation generate membrane-bound N-terminal fragments (NTFs), which we identified as novel substrates of the intramembrane proteases signal peptide peptidase-like 2a and b (SPPL2a/b). SPPL2a/b control cellular LOX-1 NTF levels which, following self-association via their transmembrane domain, can activate MAP kinases in a ligand-independent manner. This leads to an up-regulation of several pro-atherogenic and pro-fibrotic targets including ICAM-1 and the connective tissue growth factor CTGF. Consequently, SPPL2a/b-deficient mice, which accumulate LOX-1 NTFs, develop larger and more advanced atherosclerotic plaques than controls. This identifies intramembrane proteolysis by SPPL2a/b as a novel atheroprotective mechanism via negative regulation of LOX-1 signaling.

Citing Articles

The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity.

Malamud M, Brown G EMBO Rep. 2024; 25(12):5239-5264.

PMID: 39482490 PMC: 11624271. DOI: 10.1038/s44319-024-00296-2.


Selective regulation of aspartyl intramembrane protease activity by calnexin.

Contreras W, Groenendyk J, Gentzel M, Schonberg P, Buchholz F, Michalak M Cell Mol Life Sci. 2024; 81(1):441.

PMID: 39460794 PMC: 11513070. DOI: 10.1007/s00018-024-05478-8.


Dynamic association of the intramembrane proteases SPPL2a/b and their substrates with tetraspanin-enriched microdomains.

Leinung N, Mentrup T, Patel M, Gallagher T, Schroder B iScience. 2023; 26(10):107819.

PMID: 37736044 PMC: 10509304. DOI: 10.1016/j.isci.2023.107819.


The transmembrane domain of Frey1 harbors a transplantable inhibitory motif for intramembrane proteases.

Contreras W, Bazan J, Mentrup T Cell Mol Life Sci. 2023; 80(6):170.

PMID: 37261541 PMC: 10234869. DOI: 10.1007/s00018-023-04823-7.


ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?.

Maas S, Donners M, van der Vorst E Int J Mol Sci. 2023; 24(8).

PMID: 37108478 PMC: 10139114. DOI: 10.3390/ijms24087309.


References
1.
Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T . Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005; 112(6):812-8. DOI: 10.1161/CIRCULATIONAHA.104.468397. View

2.
Gijbels M, van der Cammen M, van der Laan L, Emeis J, Havekes L, Hofker M . Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis. 1999; 143(1):15-25. DOI: 10.1016/s0021-9150(98)00263-9. View

3.
Yang T, Chang P, Kuo T, Lu S . Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-κB and ERK2 activation. Atherosclerosis. 2017; 267:1-9. DOI: 10.1016/j.atherosclerosis.2017.10.016. View

4.
Langosch D, Scharnagl C, Steiner H, Lemberg M . Understanding intramembrane proteolysis: from protein dynamics to reaction kinetics. Trends Biochem Sci. 2015; 40(6):318-27. DOI: 10.1016/j.tibs.2015.04.001. View

5.
Huttl S, Klasener K, Schweizer M, Schneppenheim J, Oberg H, Kabelitz D . Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells. J Immunol. 2015; 195(4):1548-63. DOI: 10.4049/jimmunol.1403171. View